ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,641Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 392

$569K Total Retail Price of All Prescriptions

Rank: 10 out of 392

290 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 8,164 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
FUROSEMIDE 507 478 1 6
LISINOPRIL 423 349 2 1
SIMVASTATIN 316 281 3 2
OMEPRAZOLE 232 192 4 4
METOPROLOL TARTRATE 226 208 5 8
DONEPEZIL HCL 224 213 6 29
WARFARIN SODIUM 224 223 6 12
AMLODIPINE BESYLATE 219 215 8 5
METOPROLOL SUCCINATE 214 198 9 13
LEVOTHYROXINE SODIUM 209 143 10 3
LANTUS 175 152 11 41
POTASSIUM CHLORIDE 162 141 12 30
ESCITALOPRAM OXALATE 154 144 13 54
SERTRALINE HCL 151 125 14 19
METFORMIN HCL 144 99 15 9
HYDROCODONE-ACETAMINOPHEN 140 49 S3 16 14
PREDNISONE 139 113 17 39
CITALOPRAM HBR 139 103 17 15
GABAPENTIN 134 69 19 18
NOVOLOG 120 97 20 75
MIRTAZAPINE 119 83 21 35
TRAZODONE HCL 117 89 22 22
LOVASTATIN 105 58 23 23
NAMENDA 104 104 24 40
METHADONE HCL 103 0 S2 25 65
HYDROCHLOROTHIAZIDE 103 88 25 7
TRAMADOL HCL 95 63 27 25
IPRATROPIUM-ALBUTEROL 91 90 28 86
ATORVASTATIN CALCIUM 87 65 29 10
IBUPROFEN 87 32 29 64
NYSTOP 86 76 31 81
PROPRANOLOL HCL 81 43 32 99
PANTOPRAZOLE SODIUM 81 64 32 24
OXYCODONE HCL 80 20 S2 34 16
LOSARTAN POTASSIUM 77 77 35 20
RANITIDINE HCL 76 29 36 31
QUETIAPINE FUMARATE 76 63 36 47
LIDODERM 74 72 38 72
POLYETHYLENE GLYCOL 3350 73 52 39 48
PRAVASTATIN SODIUM 73 60 39 17
TAMSULOSIN HCL 72 72 41 37
CYMBALTA 68 39 42 52
DILTIAZEM 24HR CD 68 68 42 105
OXYCODONE-ACETAMINOPHEN 66 16 S2 44 33
VENLAFAXINE HCL ER 65 38 45 58
OXYCONTIN 64 0 S2 46 49
SILVER SULFADIAZINE 64 63 46 161
ADVAIR DISKUS 63 63 48 32
TRIAMCINOLONE ACETONIDE 61 61 49 91
CLONIDINE HCL 59 34 50 117
RISPERIDONE 58 48 51 59
CYCLOBENZAPRINE HCL 57 0 R 52 46
VOLTAREN 57 57 52 171
ALBUTEROL SULFATE 55 55 54 114
CLOPIDOGREL 55 55 54 70
BUPROPION HCL 55 27 54 174
ZOLPIDEM TARTRATE 52 26 57 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.